LUPINNSELupin Limited· PharmaceuticalsLowNeutral
Announced Sat, 19 Jul · 20:56 IST

Lupin Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2025 and Integrated Report for FY2024-25.

Board & Shareholder Meetings View source PDF

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lupin Limited has notified that its 43rd Annual General Meeting (AGM) will be held on Monday, August 11, 2025, at 4:00 PM IST through Video Conferencing/Other Audio-Visual Means. The notice seeks shareholder approval for a final dividend of ₹12 per equity share for FY ended March 31, 2025, with the record date set as Friday, July 25, 2025. Remote e-voting will be open from August 7 to August 10, 2025, with a cut-off date of August 4, 2025. Key business items include the adoption of audited standalone and consolidated financial statements for FY25, appointment of Ms. Punita Lal as a new Independent Director for 5 years, re-appointment of Mr. K.B.S. Anand as Independent Director for a second 5-year term, appointment of M/s. Makarand M. Joshi & Co. as Secretarial Auditors for 5 years (FY26–FY30), ratification of Cost Auditor remuneration of ₹10 lakh for FY26, and adoption of a new set of Articles of Association. The Integrated Report for FY2024-25 has also been enclosed and sent electronically to members.

Likely market impact

Shareholders holding shares as of July 25, 2025 will be eligible for the ₹12 final dividend, which will be paid within 30 days of AGM declaration subject to TDS. Investors should note the e-voting window (August 7–10) to vote on resolutions including new and continuing director appointments and the dividend. The dividend declaration signals steady shareholder returns, while the strengthening of the board with a new Independent Director (Ms. Punita Lal) brings additional expertise in healthcare, ESG, and risk management.